✦ LIBER ✦

A randomized trial of high dose interferon alfa-2b with or without ribavirin for chronic hepatitis C in non-responders to standard dose interferon

✍ Scribed by Shiva Kumar, K.; Malik, Arshad H.; Malet, Peter F.; Ostapowicz, George; Wood, Megan; Jones, Ann; Lee, William M.

Book ID: 123133329
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 175 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)81856-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with interferon alfa

Combination therapy with interferon alfa-2B, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin

✍ Hemant Pande; Paul J Thuluvath; Salim A Jaffer; Joyce Maygers 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 28 KB

Induction doses of interferon-α-2a in co

Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial

✍ J. Salmerón; M. Diago; R. Andrade; R. Pérez; R. Solá; M. Romero; M. De La Mata; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

Response to higher doses of interferon a

Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial

✍ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi

Retreatment with pegylated interferon al

Retreatment with pegylated interferon alfa-2B plus ribavirin with or without amantadine of patients with chronic hepatitis C relapsing after standard interferon and ribavirin: Results of a randomized controlled trial

✍ A. Ciancio; C. Giordanino; A. Smedile; M. Tabone; S. Martini; S. Framarin; G. Ca 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 231 KB

A randomized trial of pegylated-interfer

A randomized trial of pegylated-interferon-α2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

✍ A. CIANCIO; A. PICCIOTTO; C. GIORDANINO; A. SMEDILE; M. TABONE; A. MANCA; G. MAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

High-daily induction dose of interferon

High-daily induction dose of interferon in combination with ribavirin in chronic hepatitis C (CHC) non responder patients: a randomised controlled trial

✍ V. Leroy; N. Dutertre; A. Tran; S. Naveau; A. Abergel; J.P. Bronwicki; M. Bourli 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 132 KB